Net shares · 365d
-150.0K
0 buy · 150.0K sell
Net value · 365d
-$879.0K
$0 in · $879.0K out
Sentiment · 365d
Net selling
0% buying · 100% selling
Open-market trades · 365d
4
0 buy · 150.0K sell
Trading track record · all companies
Not enough open-market trades to chart a track record yet.
Running net of open-market buys − sells across every company. Tap the line or a marker for details. ▲ buy · ▼ sell.
Transactions · 365d
-
CLYM Grant·A
Director
$0
40.0K sh
Own New
-
CLYM Sell·S
Director · 10b5-1
$350.2K
50.0K sh · $7.00 avg · 2 lots
Own -24%
-
CLYM Sell·S
Director · 10b5-1
$528.8K
100.0K sh · $5.29 avg · 2 lots
Own -33%
-
CLYM Grant·A
Director
$0
100.4K sh
Own +49%
-
CLYM Exercise·M
Director
$0
25.1K sh
Own New
-
CLYM Exercise·M
Director
—
25.1K sh
Own +14%
| Date▾ | Ticker | Type | Shares | Value |
|---|---|---|---|---|
| Jun 5, 2026 | CLYM | Grant A | 40.0K | $0 |
| Feb 26, 2026 | CLYM | Sell S | 50.0K2 lots | $350.2K |
| Feb 13, 2026 | CLYM | Sell S | 100.0K2 lots | $528.8K |
| Aug 7, 2025 | CLYM | Grant A | 100.4K | $0 |
| Jun 27, 2025 | CLYM | Exercise M | 25.1K | $0 |
| Jun 27, 2025 | CLYM | Exercise M | 25.1K | — |
Buy Sell Non-market (grant · exercise · gift)
About Thomas Stephen Basil
This profile aggregates every SEC Form 4 insider transaction reported by Thomas Stephen Basil across all companies they trade. Open-market purchases (code P) and sales (code S) are the highest-signal, discretionary trades; grants (A), option exercises (M) and gifts (G) reflect compensation rather than conviction and carry no market price. Figures cover the selected period and update as new filings are ingested.